Welcome to the TRAJENTA® / JENTADUETO® website

This website is an international information resource intended for international healthcare professionals outside the United States of America (US) and the United Kingdom (UK) who are interested in information on TRAJENTA®/JENTADUETO®.
While the Internet serves a global community, the pharmaceutical industry is subject to country-specific regulatory considerations. This means that the registration status and approved product labels of TRAJENTA®/JENTADUETO® may not be the same in different countries.
Information on this website is derived from the Summary of Product Characteristics (SMPC) for TRAJENTA®/JENTADUETO® in the EU. It is not country-specific and may vary from the approved label in the country where you are located. Please refer to your local Prescribing Information for full details.

By clicking on the link below you are declaring and confirming that you are a healthcare professional outside the United States of America or the United Kingdom (UK), Linagliptin is approved in your country and have read and understood this disclaimer.